BMC Neurology (Mar 2020)

Midbrain/pons area ratio and clinical features predict the prognosis of progressive Supranuclear palsy

  • Shi-Shuang Cui,
  • Hua-Wei Ling,
  • Juan-Juan Du,
  • Yi-Qi Lin,
  • Jing Pan,
  • Hai-Yan Zhou,
  • Gang Wang,
  • Ying Wang,
  • Qin Xiao,
  • Jun Liu,
  • Yu-Yan Tan,
  • Sheng-Di Chen

DOI
https://doi.org/10.1186/s12883-020-01692-6
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Progressive supranuclear palsy (PSP) is a rare movement disorder with poor prognosis. This retrospective study aimed to characterize the natural history of PSP and to find predictors of shorter survival and faster decline of activity of daily living. Method All patients recruited fulfilled the movement disorder society (MDS) clinical diagnostic criteria for PSP (MDS-PSP criteria) for probable and possible PSP with median 12 years. Data were obtained including age, sex, date of onset, age at onset (AAO), symptoms reported at first visit and follow-up, date of death and date of institutionalization. Magnetic resonance imaging was collected at the first visit. Endpoints were death and institutionalization. Kaplan-Meier method and Cox proportional hazard model were used to explore factors associated with early death and institutionalization. Results Fifty-nine patients fulfilling MDS-PSP criteria were enrolled in our study. Nineteen patients (32.2%) had died and 31 patients (52.5%) were institutionalized by the end of the follow-up. Predictors associated with poorer survival were late-onset PSP and decreased M/P area ratio. Predictors associated with earlier institutionalization were older AAO and decreased M/P area ratio. Conclusion Older AAO and decreased M/P area ratio were predictors for earlier dearth and institutionalization in PSP. The neuroimaging biomarker M/P area ratio was a predictor for prognosis in PSP.

Keywords